Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
05 2020
Historique:
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 12 6 2020
Statut: ppublish

Résumé

The coronavirus disease (COVID-19) pandemic has caused tremendous pressure on hospital infrastructures such as emergency rooms (ER) and outpatient departments. To avoid malfunctioning of critical services because of large numbers of potentially infected patients seeking consultation, we established a COVID-19 rapid response infrastructure (CRRI), which instantly restored ER functionality. The CRRI was also used for testing of hospital personnel, provided epidemiological data and was a highly effective response to increasing numbers of suspected COVID-19 cases.

Identifiants

pubmed: 32489176
doi: 10.2807/1560-7917.ES.2020.25.21.2000531
pmc: PMC7268272
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Références

Infection. 2020 Apr;48(2):151-153
pubmed: 32185635
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Lancet Infect Dis. 2020 May;20(5):e102-e107
pubmed: 32145768
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Science. 2020 Apr 29;:
pubmed: 32350060
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156330
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JCI Insight. 2020 May 21;5(10):
pubmed: 32352933

Auteurs

Max Augustin (M)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
These authors contributed equally to this article.

Philipp Schommers (P)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
These authors contributed equally to this article.
Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Isabelle Suárez (I)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
These authors contributed equally to this article.

Philipp Koehler (P)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Department I of Internal Medicine, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.

Henning Gruell (H)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Florian Klein (F)

German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Christian Maurer (C)

Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Köln, Düsseldorf, University of Cologne, Cologne, Germany.

Petra Langerbeins (P)

Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Köln, Düsseldorf, University of Cologne, Cologne, Germany.

Vanessa Priesner (V)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.

Kirsten Schmidt-Hellerau (K)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.

Jakob J Malin (JJ)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.

Melanie Stecher (M)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.

Norma Jung (N)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.

Gerhard Wiesmüller (G)

Public Health Department Cologne, Cologne, Germany.

Arne Meissner (A)

Department of Hospital Hygiene and Infection Control, University Hospital Cologne, Cologne, Germany.

Janine Zweigner (J)

Department of Hospital Hygiene and Infection Control, University Hospital Cologne, Cologne, Germany.

Georg Langebartels (G)

Department for Clinical Affairs, University of Cologne, Germany.

Felix Kolibay (F)

Department for Clinical Affairs, University of Cologne, Germany.

Victor Suárez (V)

Department II of Internal Medicine (Nephrology, Rheumatology, Diabetes, and General Internal Medicine) and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Volker Burst (V)

Department II of Internal Medicine (Nephrology, Rheumatology, Diabetes, and General Internal Medicine) and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Philippe Valentin (P)

Department II of Internal Medicine (Nephrology, Rheumatology, Diabetes, and General Internal Medicine) and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.

Dirk Schedler (D)

University of Cologne, Medical Faculty and University Hospital Cologne, Department of Anaesthesiology and Intensive Care Medicine, Cologne, Germany.

Oliver A Cornely (OA)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Department I of Internal Medicine, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany.

Michael Hallek (M)

University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Köln, Düsseldorf, University of Cologne, Cologne, Germany.

Gerd Fätkenheuer (G)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.

Jan Rybniker (J)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
These authors contributed equally to this article.

Clara Lehmann (C)

University of Cologne, Department I of Internal Medicine, Division of Infectious Diseases, Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany.
These authors contributed equally to this article.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH